Susquehanna International Group, LLP Aravive, Inc. Put Options Transaction History

Susquehanna International Group, LLP

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2023 May 16, 2023	SELL	$1.29 - $2.46 $15,222 - $29,028	-11,800 Reduced 33.43%	23,500 $47,000
Q4 2022 Feb 14, 2023	BUY	$1.2 - $1.83 $42,360 - $64,599	35,300 New	35,300 $46,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.